Vensica Medical
Needle-free Drug Delivery System for the Urinary Bladder
Company Overview
Snapshot
Founded in August 2014 by Avner Geva and Avi Eftel, Vensica Medical operates with 11–50 employees. The company has secured $33.2 million in total capital across 6 funding rounds from 9 investors. In October 2024, Vensica Medical secured an $11 million funding round from Israel Biotech Fund to support Phase 2 trials for overactive bladder treatment.
Business overview
Vensica Medical is a Health Tech & Life Sciences company developing ViXe, a product that integrates Xeomin, a commercial neurotoxin, with Vibe, a needle-free, ultrasound drug delivery device. The Vibe platform is designed for uniform, controlled, and localized drug delivery directly into the bladder wall for urology applications. Leveraging disruptive ultrasound technology, Vibe creates cavitation bubbles to microinject drugs precisely, serving the healthcare and medical devices sectors by offering a less invasive treatment for conditions like overactive bladder.
Strategic signal
In October 2024, Vensica Medical secured an $11 million funding round from Israel Biotech Fund, with strategic partners Merz and Laborie, to advance its needle-free botulinum toxin A delivery system for overactive bladder treatment. This investment will support Phase 2 clinical trials in the US and Europe, signaling strong investor confidence in Vensica's innovative approach to urology therapeutics and its potential to transform patient care by offering a minimally invasive alternative to traditional injections.
Log in to access full profile ›Company Intelligence Q&A
- What significant funding did Vensica Medical secure recently?
- In October 2024, Vensica Medical secured an $11 million funding round from Israel Biotech Fund to support Phase 2 trials for overactive bladder treatment.
- What was the outcome of Vensica Medical's funding round in February 2022?
- In February 2022, Vensica Medical closed a funding round with participation from.
- Which investors participated in Vensica Medical's November 2021 funding round?
- In November 2021, Vensica Medical closed an investment round led by.
- What was the nature of Cogentix Medical's investment in Vensica Medical?
- In September 2017, Cogentix Medical made an investment in.
- When was Vensica Medical founded and by whom?
- Vensica Medical was founded in August 2014 by Avner Geva and Avi Eftel.